Nebenwirkungen · ProQuad
ProQuad powder and solvent for suspension for injection ProQuad powder and solvent for suspension for injection in a pre-filled syringe Measles, mumps, rubella and varicella vaccine (live). · Abschnitt 4.8 · PDF-Seite 8
HOS-114568 · Präparat HOS-094113
The following adverse reactions were reported as vaccine related by the investigator in individuals after a single dose of ProQuad. Several adverse events were solicited in the clinical studies and are designated with the symbol (‡). Additionally, other adverse events have been reported with post- marketing use of ProQuad and/or in clinical studies and post-marketing use of either the measles, mumps, and rubella vaccine manufactured by MSD, the monovalent component vaccines of the measles, mumps, and rubella vaccine manufactured by MSD, or Varicella Vaccine live (Oka/Merck). The frequency of these adverse events is qualified as "not known" when it cannot be estimated based on the available data.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-09-25T13:47:00Z · SHA-256 10f5a1e20845cc2273c111fca146c4950a4ba676fc814ddf4efcc5e150ea48b9 · Passage 21f6f3754bab0a6ea9d2067b02438f34fde0918f0218748784e3141e77b58d9f · Zeichen 4198–4902 im Abschnitt